Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

Montefiore Medical Center, The Bronx

National Translational Research Group, Inc., East Setauket

Premier Medical Group of the Hudson Valley, Poughkeepsie

Associated Medical Professionals of NY, PLLC, Syracuse

Urologic Consultants of SE PA, Bala-Cynwyd

Howard University Cancer Center, Washington D.C.

Chesapeake Urology Research Associates, Towson

Urology of Virginia, PLLC, Virginia Beach

Raleigh Hematology Oncology Associates, D.B.A., Cancer Centers of North Carolina, Raleigh

Carolina Urology Partners, Gastonia

South Carolina Oncology Associates, Columbia

Carolina Urologic Research Center, Myrtle Beach

Urology Associates, P.C., Nashville

TriState Urologic Services PSC Inc., dba The Urology Group, Cincinnati

First Urology, PSC, Jeffersonville

Michigan Institute of Urology, Troy

Henry Ford Health System, Detroit

St. Louis Cancer Care, LLP, Bridgeton

St. Louis Cancer Care, LLP, St Louis

Cancer Center of Kansas, Wichita

Southeast Nebraska Hematology & Oncology Consultants, P.C. d/b/a Southeast Nebraska Cancer Center, Lincoln

Tulane University, New Orleans

Highland Clinic, Shreveport

Urologic Specialists of Oklahoma, Tulsa

The Urology Center of Colorado, Denver

21st Century Oncology, Scottsdale

Tower Urology / Tower Research Institute, Los Angeles

Prostate Oncology Specialists, Inc., Marina del Rey

Northwest Cancer Specialists, PC, Tualatin

Providence Health & Services, Portland

Oregon Urology Institute, Springfield

University of Washington Medical Centerl, Seattle

Tufts Medical Center, Boston

Comprehensive Cancer Centers of Nevada, Henderson

Comprehensive Cancer Centers of Nevada, Las Vegas

Delaware Valley Urology, LLC, Mount Laurel

Texas Oncology - Fort Worth, Fort Worth

Seattle Cancer Care Alliance, Seattle

Northwest Cancer Specialists, Vancouver